Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0725

+3.6%

Oct 31 3:52 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Howard Williams	6/27/2014 1:34:25 PM
	of 13111

Today (Friday), EADO event, Munich: melanomaglobal2014.org 08:00 - 10:00 SYMPOSIUM IV New drugs and trials: An update on immunotherapy and chemotherapy 09:24 - 09:34 PV-10 Vernon Sondak, Tampa, USA [That'd be Moffitt] Topics in the session, in sequence: Ipilimumab, Nivolumab, MK3475, Biomarkers for PD-1 response, IL19, MAGE-A3 ASCI, T_VEC, PV-10, Electroporation, Nab-paclitaxel

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next